{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2013-N-1525\" sorted by posted_date descending", "rows": [["FDA-2013-N-1525-0229", "FDA", "FDA-2013-N-1525", "National Plan to Address Alzheimer's Disease RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX", "Supporting & Related Material", "Background Material", "2015-03-23T04:00:00Z", 2015, 3, null, null, "2015-03-23T19:37:58Z", null, 0, 0, "09000064818accea"], ["FDA-2013-N-1525-0207", "FDA", "FDA-2013-N-1525", "Cited Reference Martin-Moreno et al Prolonged Oral Cannabinoid Administration Prevents Neuroinflammation, Lowers b-amyloid\nLevels and Improves Cognitive Performance in Tg APP 2576 Mice RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX", "Supporting & Related Material", "Background Material", "2014-10-17T04:00:00Z", 2014, 10, null, null, "2015-03-23T19:51:17Z", null, 0, 0, "09000064818ad191"], ["FDA-2013-N-1525-0206", "FDA", "FDA-2013-N-1525", "Pacher, Pal et al  The Endocannabinoid System as an Emerging Target\nof Pharmacotherapy RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX", "Supporting & Related Material", "Background Material", "2014-10-17T04:00:00Z", 2014, 10, null, null, "2015-03-23T19:31:29Z", null, 0, 0, "09000064818acc5d"], ["FDA-2013-N-1525-0122", "FDA", "FDA-2013-N-1525", "Attachment 1 Cited Article RE: Nomination from Hopkinton Drug", "Supporting & Related Material", "Background Material", "2014-09-19T04:00:00Z", 2014, 9, null, null, "2014-09-19T19:08:09Z", null, 0, 0, "090000648185c738"], ["FDA-2013-N-1525-0127", "FDA", "FDA-2013-N-1525", "Attachment 6 WHO Guidelines for Indoor Air Quality RE: Nominaton from Hopkinton Drug", "Supporting & Related Material", "Background Material", "2014-09-19T04:00:00Z", 2014, 9, null, null, "2014-09-19T19:27:24Z", null, 0, 0, "090000648185c7b4"], ["FDA-2013-N-1525-0128", "FDA", "FDA-2013-N-1525", "Attachment 7 Policyholders of America Research Committee Report on Diagnosis and Treatement of C.I.R.S RE: Nomination from Hopkinton Drug", "Supporting & Related Material", "Background Material", "2014-09-19T04:00:00Z", 2014, 9, null, null, "2014-09-19T19:33:52Z", null, 0, 0, "090000648185c7b6"], ["FDA-2013-N-1525-0120", "FDA", "FDA-2013-N-1525", "Attachment A Bibliography RE: Nomination from Hopkinton Drug", "Supporting & Related Material", "Background Material", "2014-09-19T04:00:00Z", 2014, 9, null, null, "2014-09-19T19:00:55Z", null, 0, 0, "090000648185c6e5"], ["FDA-2013-N-1525-0121", "FDA", "FDA-2013-N-1525", "Attachment B Letter from Hopkinton Drug Dated August 20, 2014 RE: Nomination from Hopkinton Drug", "Supporting & Related Material", "Background Material", "2014-09-19T04:00:00Z", 2014, 9, null, null, "2014-09-19T19:00:43Z", null, 0, 0, "090000648185c715"], ["FDA-2013-N-1525-0123", "FDA", "FDA-2013-N-1525", "Attachment 2 Cited Reference RE: Nomination from Hopkinton Drug", "Supporting & Related Material", "Background Material", "2014-09-19T04:00:00Z", 2014, 9, null, null, "2014-09-19T19:07:57Z", null, 0, 0, "090000648185c74e"], ["FDA-2013-N-1525-0125", "FDA", "FDA-2013-N-1525", "Attachment 4 Transcript RE: Nomination from Hopkinton Drug", "Supporting & Related Material", "Background Material", "2014-09-19T04:00:00Z", 2014, 9, null, null, "2014-09-19T19:12:46Z", null, 0, 0, "090000648185c786"], ["FDA-2013-N-1525-0124", "FDA", "FDA-2013-N-1525", "Attachment 3 VIP Efficacy Summary RE: Nomination from Hopkinton Drug", "Supporting & Related Material", "Background Material", "2014-09-19T04:00:00Z", 2014, 9, null, null, "2014-09-19T19:07:33Z", null, 0, 0, "090000648185c769"], ["FDA-2013-N-1525-0126", "FDA", "FDA-2013-N-1525", "Attachment 5 GAO Indoor Mold Report September 2008 RE: Nomination from Hopkinton Drug", "Supporting & Related Material", "Background Material", "2014-09-19T04:00:00Z", 2014, 9, null, null, "2014-09-19T19:20:26Z", null, 0, 0, "090000648185c7af"], ["FDA-2013-N-1525-0016", "FDA", "FDA-2013-N-1525", "Bulk Drug Substances That May Be Used To Compound Drug Products in\nAccordance With Section 503A of the Federal Food, Drug, and Cosmetic Act; Revised Request for Nominations", "Notice", "Request for Nominations", "2014-07-02T04:00:00Z", 2014, 7, "2014-07-02T04:00:00Z", "2014-10-01T03:59:59Z", "2014-11-02T01:09:57Z", "2014-15367", 0, 0, "0900006481787042"], ["FDA-2013-N-1525-0001", "FDA", "FDA-2013-N-1525", "List of Bulk Drug Substances That May Be Used in Pharmacy Compounding; Bulk Drug Substances That May Be Used To Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act", "Proposed Rule", "Withdrawal", "2013-12-04T05:00:00Z", 2013, 12, "2013-12-04T05:00:00Z", "2014-03-05T04:59:59Z", "2014-10-03T01:02:26Z", "2013-28979", 0, 0, "09000064814a631f"]], "truncated": false, "filtered_table_rows_count": 14, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2013-N-1525"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2013-N-1525", "results": [{"value": "FDA", "label": "FDA", "count": 14, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2013-N-1525", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&document_type=Notice", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2013-N-1525", "results": [{"value": 2014, "label": 2014, "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&posted_year=2014", "selected": false}, {"value": 2013, "label": 2013, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&posted_year=2013", "selected": false}, {"value": 2015, "label": 2015, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&posted_year=2015", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2013-N-1525&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 9.068637038581073, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}